| dc.identifier.citation | Thomas A Pollak PhD , Belinda R Lennox DM , Sabine Müller PhD , Michael E Benros PhD , Harald Prüss MD , Ludger Tebartz van Elst Prof , Hans Klein MD , Johann Steiner Prof , Thomas Frodl Prof , Bernhard Bogerts Prof , Li Tian PhD , Laurent Groc PhD , Alkomiet Hasan Prof , Bernhard T Baune Prof , Dominique Endres MD , Ebrahim Haroon MD , Robert Yolken Prof , Francesco Benedetti MD , Angelos Halaris MD , Jeffrey H Meyer MD PhD , Hans Stassen PhD , Marion Leboyer Prof , Dietmar Fuchs PhD , Markus Otto Prof , David A Brown Prof , Angela Vincent Prof , Souhel Najjar Prof and Karl Bechter Prof. Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. Nov 4 2019 | en |
| dc.description.abstract | There is increasing recognition in the neurological and psychiatric literature of patients with so-called isolated
psychotic presentations (ie, with no, or minimal, neurological features) who have tested positive for neuronal
autoantibodies (principally N-methyl-D-aspartate receptor antibodies) and who have responded to immunotherapies.
Although these individuals are sometimes described as having atypical, mild, or attenuated forms of autoimmune
encephalitis, some authors feel that that these cases are sufficiently different from typical autoimmune encephalitis to
establish a new category of so-called autoimmune psychosis. We briefly review the background, discuss the existing
evidence for a form of autoimmune psychosis, and propose a novel, conservative approach to the recognition of
possible, probable, and definite autoimmune psychoses for use in psychiatric practice. We also outline the investigations
required and the appropriate therapeutic approaches, both psychiatric and immunological, for probable and definite
cases of autoimmune psychoses, and discuss the ethical issues posed by this challenging diagnostic category. | en |